GRAIL, Inc. (GRAL)
58.51
-0.08
(-0.14%)
USD |
NASDAQ |
Jun 11, 09:45
GRAIL Market Cap : 2.407B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 2.410B |
| June 09, 2026 | 2.505B |
| June 08, 2026 | 2.531B |
| June 05, 2026 | 2.467B |
| June 04, 2026 | 2.737B |
| June 03, 2026 | 2.515B |
| June 02, 2026 | 2.464B |
| June 01, 2026 | 2.649B |
| May 29, 2026 | 2.948B |
| May 28, 2026 | 3.041B |
| May 27, 2026 | 3.065B |
| May 26, 2026 | 2.960B |
| May 22, 2026 | 2.884B |
| May 21, 2026 | 2.912B |
| May 20, 2026 | 2.834B |
| May 19, 2026 | 2.617B |
| May 18, 2026 | 2.605B |
| May 15, 2026 | 2.560B |
| May 14, 2026 | 2.652B |
| May 13, 2026 | 2.595B |
| May 12, 2026 | 2.660B |
| May 11, 2026 | 2.629B |
| May 08, 2026 | 2.645B |
| May 07, 2026 | 2.700B |
| May 06, 2026 | 2.693B |
| Date | Value |
|---|---|
| May 05, 2026 | 2.335B |
| May 04, 2026 | 2.389B |
| May 01, 2026 | 2.320B |
| April 30, 2026 | 2.338B |
| April 29, 2026 | 2.038B |
| April 28, 2026 | 2.141B |
| April 27, 2026 | 2.257B |
| April 24, 2026 | 2.232B |
| April 23, 2026 | 2.078B |
| April 22, 2026 | 2.158B |
| April 21, 2026 | 2.094B |
| April 20, 2026 | 2.100B |
| April 17, 2026 | 2.121B |
| April 16, 2026 | 2.029B |
| April 15, 2026 | 2.042B |
| April 14, 2026 | 2.071B |
| April 13, 2026 | 1.971B |
| April 10, 2026 | 1.872B |
| April 09, 2026 | 1.951B |
| April 08, 2026 | 2.083B |
| April 07, 2026 | 2.016B |
| April 06, 2026 | 2.122B |
| April 02, 2026 | 2.256B |
| April 01, 2026 | 2.199B |
| March 31, 2026 | 2.120B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Apogee Therapeutics, Inc. | 6.294B |
| Evommune, Inc. | 738.02M |
| Arrowhead Pharmaceuticals, Inc. | 9.976B |
| Oncolytics Biotech, Inc. | 91.74M |
| Sangamo Therapeutics, Inc. | 61.73M |
Market Cap Related Metrics
| PS Ratio | 14.36 |
| Price to Book Value | 0.9625 |
| Price | 58.51 |
| Earnings Yield | -17.73% |